InterCure Statistics
Total Valuation
InterCure has a market cap or net worth of $134.90 million. The enterprise value is $147.20 million.
| Market Cap | 134.90M |
| Enterprise Value | 147.20M |
Important Dates
The next estimated earnings date is Tuesday, May 14, 2024, before market open.
| Earnings Date | May 14, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
InterCure has 45.57 million shares outstanding. The number of shares has increased by 0.97% in one year.
| Shares Outstanding | 45.57M |
| Shares Change (YoY) | +0.97% |
| Shares Change (QoQ) | +0.97% |
| Owned by Insiders (%) | 35.80% |
| Owned by Institutions (%) | 10.92% |
| Float | 32.21M |
Valuation Ratios
The trailing PE ratio is 24.67 and the forward PE ratio is 6.94.
| PE Ratio | 24.67 |
| Forward PE | 6.94 |
| PS Ratio | 1.20 |
| Forward PS | 0.42 |
| PB Ratio | 1.00 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 33.52 |
| EV / Sales | 1.31 |
| EV / EBITDA | n/a |
| EV / EBIT | 22.19 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.90, with a Debt / Equity ratio of 0.32.
| Current Ratio | 1.90 |
| Quick Ratio | 1.21 |
| Debt / Equity | 0.32 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 1.20 |
Financial Efficiency
Return on equity (ROE) is 3.30% and return on invested capital (ROIC) is 16.27%.
| Return on Equity (ROE) | 3.30% |
| Return on Assets (ROA) | 1.80% |
| Return on Capital (ROIC) | 16.27% |
| Revenue Per Employee | $303,810 |
| Profits Per Employee | $11,868 |
| Employee Count | 370 |
| Asset Turnover | 0.47 |
| Inventory Turnover | 2.15 |
Taxes
| Income Tax | -3.19M |
| Effective Tax Rate | -266.42% |
Stock Price Statistics
The stock price has increased by +30.94% in the last 52 weeks. The beta is 0.24, so InterCure's price volatility has been lower than the market average.
| Beta (1Y) | 0.24 |
| 52-Week Price Change | +30.94% |
| 50-Day Moving Average | 2.28 |
| 200-Day Moving Average | 1.62 |
| Relative Strength Index (RSI) | 69.41 |
| Average Volume (30 Days) | 79,431 |
Short Selling Information
The latest short interest is 56,193, so 0.12% of the outstanding shares have been sold short.
| Short Interest | 56,193 |
| Short Previous Month | 90,193 |
| Short % of Shares Out | 0.12% |
| Short % of Float | 0.17% |
| Short Ratio (days to cover) | 0.55 |
Income Statement
In the last 12 months, InterCure had revenue of $112.41 million and earned $4.39 million in profits. Earnings per share was $0.12.
| Revenue | 112.41M |
| Gross Profit | 37.02M |
| Operating Income | 7.56M |
| Pretax Income | 1.12M |
| Net Income | 4.39M |
| EBITDA | n/a |
| EBIT | 6.63M |
| Earnings Per Share (EPS) | $0.12 |
Balance Sheet
The company has $31.05 million in cash and $43.36 million in debt, giving a net cash position of -$12.30 million or -$0.27 per share.
| Cash & Cash Equivalents | 31.05M |
| Total Debt | 43.36M |
| Net Cash | -12.30M |
| Net Cash Per Share | -$0.27 |
| Equity / Book Value | 135.46M |
| Book Value Per Share | 2.97 |
| Working Capital | 49.72M |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 32.93%, with operating and profit margins of 6.73% and 3.91%.
| Gross Margin | 32.93% |
| Operating Margin | 6.73% |
| Pretax Margin | 1.00% |
| Profit Margin | 3.91% |
| EBITDA Margin | n/a |
| EBIT Margin | 5.90% |
| FCF Margin | n/a |
Dividends & Yields
InterCure does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.97% |
| Shareholder Yield | -0.97% |
| Earnings Yield | 3.26% |
| FCF Yield | n/a |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on April 9, 2021. It was a reverse split with a ratio of 877:3902.
| Last Split Date | Apr 9, 2021 |
| Split Type | Reverse |
| Split Ratio | 877:3902 |
Scores
InterCure has an Altman Z-Score of 1.61 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.61 |
| Piotroski F-Score | 5 |